Drug Shortage Report for TEVA-AMPHETAMINE XR
Report ID | 236398 |
Drug Identification Number | 02439255 |
Brand name | TEVA-AMPHETAMINE XR |
Common or Proper name | AMPHETAMINE XR 15MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MIXED SALTS AMPHETAMINE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-08-28 |
Estimated end date | 2025-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2025-05-02 | French | Compare |
v21 | 2025-05-02 | English | Compare |
v20 | 2025-04-24 | French | Compare |
v19 | 2025-04-24 | English | Compare |
v18 | 2025-04-04 | French | Compare |
v17 | 2025-04-04 | English | Compare |
v16 | 2025-03-06 | French | Compare |
v15 | 2025-03-06 | English | Compare |
v14 | 2025-02-13 | French | Compare |
v13 | 2025-02-13 | English | Compare |
v12 | 2025-01-30 | French | Compare |
v11 | 2025-01-30 | English | Compare |
v10 | 2024-12-04 | French | Compare |
v9 | 2024-12-04 | English | Compare |
v8 | 2024-11-21 | French | Compare |
v7 | 2024-11-21 | English | Compare |
v6 | 2024-11-01 | French | Compare |
v5 | 2024-11-01 | English | Compare |
v4 | 2024-10-17 | French | Compare |
v3 | 2024-10-17 | English | Compare |